CSPC Pharmaceutical Group Limited (1093.HK)

HKD 4.79

(0.84%)

EBITDA Summary of CSPC Pharmaceutical Group Limited

  • CSPC Pharmaceutical Group Limited's latest annual EBITDA in 2023 was 8.53 Billion HKD , down -1.56% from previous year.
  • CSPC Pharmaceutical Group Limited's latest quarterly EBITDA in 2024 Q2 was 4.56 Billion HKD , down 0.0% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported an annual EBITDA of 8.65 Billion HKD in 2022, up 6.32% from previous year.
  • CSPC Pharmaceutical Group Limited reported an annual EBITDA of 9.27 Billion HKD in 2021, up 22.17% from previous year.
  • CSPC Pharmaceutical Group Limited reported a quarterly EBITDA of 4.42 Billion HKD for 2023 Q4, up 128.75% from previous quarter.
  • CSPC Pharmaceutical Group Limited reported a quarterly EBITDA of 1.93 Billion CNY for 2023 Q3, up 1.44% from previous quarter.

Annual EBITDA Chart of CSPC Pharmaceutical Group Limited (2023 - 2003)

Historical Annual EBITDA of CSPC Pharmaceutical Group Limited (2023 - 2003)

Year EBITDA EBITDA Growth
2023 8.53 Billion HKD -1.56%
2022 8.65 Billion HKD 6.32%
2021 9.27 Billion HKD 22.17%
2020 8.08 Billion HKD 20.29%
2019 5.35 Billion HKD 23.81%
2018 5.31 Billion HKD 63.07%
2017 4.19 Billion HKD -0.84%
2016 3.24 Billion HKD 26.04%
2015 2.75 Billion HKD 27.28%
2014 2.28 Billion HKD 18.53%
2013 1.54 Billion HKD -25.28%
2012 2.55 Billion HKD 161.91%
2011 782.59 Million HKD -41.87%
2010 1.6 Billion HKD -5.37%
2009 1.69 Billion HKD -3.96%
2008 1.68 Billion HKD 48.63%
2007 1.06 Billion HKD 197.65%
2006 435.48 Million HKD -21.75%
2005 427.85 Million HKD -12.73%
2004 616.91 Million HKD -40.21%
2003 822.97 Million HKD 0.0%

Peer EBITDA Comparison of CSPC Pharmaceutical Group Limited

Name EBITDA EBITDA Difference